We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
IQVIA Earnings & Revenues Beat Estimates in Q1, Increase Y/Y
Read MoreHide Full Article
IQVIA Holdings Analytics Inc. (IQV - Free Report) has reported impressive first-quarter 2025 results, wherein earnings and revenues beat the Zacks Consensus Estimate.
Adjusted earnings were $2.70 per share, outpacing the Zacks Consensus Estimate by 2.7% and rising 6.3% on a year-over-year basis. Total revenues of $3.8 billion surpassed the consensus estimate by 1.6% and grew 2.5% from the year-ago quarter.
The IQV stock has lost 33.5% over the past year compared with the 11.5% decline of the industry it belongs to and against the 9.1% rise of the Zacks S&P 500 Composite.
IQVIA’s Quarterly Details
The Research and Development segment’s revenues were $2.1 billion, increasing marginally from the year-ago quarter and 1.1% on a constant-currency basis. The metric met our estimate.
IQVIA Holdings Inc. Price, Consensus and EPS Surprise
Revenues from the Technology and Analytics segment were $1.5 billion, growing 6.4% from the year-ago quarter and 7.6% on a constant-currency basis. The metric met our estimate.
Contract Sales and Medical Solutions revenues decreased 4.2% on a year-over-year basis to $181 million and increased 2.1% on a constant-currency basis. The metric missed our estimation of $192.4 million.
Adjusted EBITDA for the first quarter of 2025 was $883 million, a 2.4% rise from the year-ago quarter and lagging our projection of $886.6 million.
The company exited the quarter with cash and cash equivalents of $1.7 billion, flat with the preceding quarter. Long-term debt (less current portion) was $13.1 billion compared with $12.8 billion at the end of the fourth quarter of 2024.
Net cash generated from operating activities was $586 million and the capital expenditure for the quarter was $142 million. The company generated a free cash flow of $426 million in the quarter.
IQV’s 2025 Guidance
For 2025, IQVIA has raised its revenue guidance to $16.00-$16.40 billion from the preceding quarter’s view of $15.72-$16.12 billion. The guided range is higher than the Zacks Consensus Estimate for revenues of $15.86 billion.
The company expects an adjusted EPS of $11.70-$12.10. The mid-point ($11.90) of the guided range is higher than the Zacks Consensus Estimate for earnings of $11.84.
IQVIA’s adjusted EBITDA view for the same period is $3.76-$3.88 billion.
The Interpublic Group of Companies, Inc. (IPG - Free Report) reported mixed first-quarter 2025 results.
IPG’s adjusted earnings of 33 cents per share surpassed the Zacks Consensus Estimate by 10% but decreased 8.3% from the year-ago quarter. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)
Revenues before billable expenses (net revenues) of $2 billion missed the consensus estimate by a slight margin and declined 8.3% year over year.
WCN’s adjusted earnings (excluding 20 cents from non-recurring items) of $1.13 per share surpassed the Zacks Consensus Estimate by 5.6% and increased 8.7% year over year. Revenues of $2.2 billion beat the consensus estimate marginally and grew 7.5% from the year-ago quarter.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
IQVIA Earnings & Revenues Beat Estimates in Q1, Increase Y/Y
IQVIA Holdings Analytics Inc. (IQV - Free Report) has reported impressive first-quarter 2025 results, wherein earnings and revenues beat the Zacks Consensus Estimate.
Adjusted earnings were $2.70 per share, outpacing the Zacks Consensus Estimate by 2.7% and rising 6.3% on a year-over-year basis. Total revenues of $3.8 billion surpassed the consensus estimate by 1.6% and grew 2.5% from the year-ago quarter.
The IQV stock has lost 33.5% over the past year compared with the 11.5% decline of the industry it belongs to and against the 9.1% rise of the Zacks S&P 500 Composite.
IQVIA’s Quarterly Details
The Research and Development segment’s revenues were $2.1 billion, increasing marginally from the year-ago quarter and 1.1% on a constant-currency basis. The metric met our estimate.
IQVIA Holdings Inc. Price, Consensus and EPS Surprise
IQVIA Holdings Inc. price-consensus-eps-surprise-chart | IQVIA Holdings Inc. Quote
Revenues from the Technology and Analytics segment were $1.5 billion, growing 6.4% from the year-ago quarter and 7.6% on a constant-currency basis. The metric met our estimate.
Contract Sales and Medical Solutions revenues decreased 4.2% on a year-over-year basis to $181 million and increased 2.1% on a constant-currency basis. The metric missed our estimation of $192.4 million.
Adjusted EBITDA for the first quarter of 2025 was $883 million, a 2.4% rise from the year-ago quarter and lagging our projection of $886.6 million.
The company exited the quarter with cash and cash equivalents of $1.7 billion, flat with the preceding quarter. Long-term debt (less current portion) was $13.1 billion compared with $12.8 billion at the end of the fourth quarter of 2024.
Net cash generated from operating activities was $586 million and the capital expenditure for the quarter was $142 million. The company generated a free cash flow of $426 million in the quarter.
IQV’s 2025 Guidance
For 2025, IQVIA has raised its revenue guidance to $16.00-$16.40 billion from the preceding quarter’s view of $15.72-$16.12 billion. The guided range is higher than the Zacks Consensus Estimate for revenues of $15.86 billion.
The company expects an adjusted EPS of $11.70-$12.10. The mid-point ($11.90) of the guided range is higher than the Zacks Consensus Estimate for earnings of $11.84.
IQVIA’s adjusted EBITDA view for the same period is $3.76-$3.88 billion.
IQV carries a Zacks Rank #3 (Hold) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Earnings Snapshot of Peers
The Interpublic Group of Companies, Inc. (IPG - Free Report) reported mixed first-quarter 2025 results.
IPG’s adjusted earnings of 33 cents per share surpassed the Zacks Consensus Estimate by 10% but decreased 8.3% from the year-ago quarter. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)
Revenues before billable expenses (net revenues) of $2 billion missed the consensus estimate by a slight margin and declined 8.3% year over year.
Waste Connections, Inc. (WCN - Free Report) posted impressive first-quarter 2025 results.
WCN’s adjusted earnings (excluding 20 cents from non-recurring items) of $1.13 per share surpassed the Zacks Consensus Estimate by 5.6% and increased 8.7% year over year. Revenues of $2.2 billion beat the consensus estimate marginally and grew 7.5% from the year-ago quarter.